The findings have demonstrated that individuals chronically infected with HCV-G3 have significantly decreased serum apoB, and non-HDL cholesterol concentrations, in conjunction with more hepatic steatosis than those with HCV-G1. Here, APOB is linked to Hepatic steatosis.